Prescient Therapeutics
Advertisement
Prescient Therapeutics, located in South Melbourne, is a clinical-stage oncology company focused on developing targeted therapies for cancer treatment. Their leading-edge technologies include the first-in-class PTX100, which aims to disrupt the RAS family pathway and is currently in a Phase 2 clinical study for refractory relapsed Cutaneous T-Cell Lymphoma.
Additionally, the company is advancing its innovative CellPryme cell therapy platform to enhance CAR T-cell efficacy and the OmniCAR platform, which addresses the challenges of conventional CAR T therapy. Collaborating with renowned institutions such as Yale and Oxford, Prescient Therapeutics is committed to transforming cancer treatment through personalized medicine approaches.
Generated from the website
Also at this address
You might also like
Advertisement